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Abstract:  The  characterization  results  of  the  localized  surface  plasmon 
resonance  (LSPR)  of  Au  nanorings  (NRs)  with  optical  coherence 
tomography (OCT) are first demonstrated. Then, the diffusion behaviors of 
Au NRs in mouse liver samples tracked with OCT are shown. For such 
research, aqueous solutions of Au NRs with two different localized surface 
plasmon  resonance  (LSPR)  wavelengths  are  prepared  and  characterized. 
Their LSPR-induced extinction cross sections at 1310 nm are estimated with 
OCT  scanning  of  solution  droplets  on  coverslip  to  show  reasonably 
consistent results with the data at individual LSPR wavelengths and at 1310 
nm  obtained  from  transmission  measurements  of  Au  NR  solutions  and 
numerical simulations. The resonant and non-resonant Au NRs are delivered 
into  mouse  liver  samples  for  tracking  Au  NR  diffusion  in  the  samples 
through continuous OCT scanning for one hour. With resonant Au NRs, the 
average  A-mode  scan  profiles  of  OCT  scanning  at  different  delay  times 
clearly demonstrate the extension of strong backscattering depth with time. 
The  calculation  of  speckle  variance  among  successive  OCT  scanning 
images, which is related to the local transport speed of Au NRs, leads to the 
illustrations  of  downward  propagation  and  spreading  of  major  Au  NR 
motion spot with time. 
©2010 Optical Society of America 
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1. Introduction 
With their localized surface plasmon resonance (LSPR) features for enhancing scattering and 
absorption in a bio-tissue, biocompatible metal nanoparticles (NPs), particularly Au NPs, have 
found  broad  biomedical  applications,  including  contrast  enhancement  in  optical  imaging  
[1–10],  photothermal  therapy  [9,11–25],  and  drug  delivery  [26–29].  Through  a  bio-
conjugation  process,  targeted  multi-function  operation  can  be  implemented  [30–35].  For 
realizing those applications, metal NP distribution in a bio-tissue becomes an important issue. 
In the cell level, metal NP internalization or expulsion by cells controls the effectiveness of 
photothermal  therapy  and  drug  delivery.  In  the  organ  level,  the  larger-scale  metal  NP 
distribution determines the effective coverage of a lesion for diagnosis (imaging) and therapy 
(heating or drug delivery). Cell uptake and intercellular transport of metal NPs have been 
widely  studied  [36–44].  Based  on  the  Brownian  diffusion  model,  the  Au  NP  diffusion 
coefficient in zebrafish embryos has been estimated [41]. However, from literature survey, the 
study of metal NP distribution, when they are delivered into a bio-tissue of a larger scale (in 
the mm range), is quite rare. To develop more effective LSPR-related diagnosis and therapy 
techniques, investigations of metal NP distribution and their transport process in a bio-tissue 
sample are needed. 
Among various metal NPs used for aforementioned biomedical applications, so far the 
most commonly used include Au sphere-like NP [45], Au nanoshell [46–48], Au nanorod  
[49–52],  and Au nanocage [5,6,53,54],  all of which are fabricated with the techniques of 
chemical synthesis. Although Ag NPs were also used [41], Au NPs are preferred because of 
their long-term biocompatibility [55]. However, their LSPR wavelengths are limited to the 
spectral range shorter than 900 nm in wavelength. Although it is feasible to fabricate Au 
nanoshells and nanorods for achieving longer LSPR wavelengths, their NP uniformity and 
fabrication yield become quite low [56,57]. Because of the weaker tissue scattering at a longer 
wavelength,  ~1300  nm  in  wavelength  is  an  attractive  spectral  position  in  bio-photonics 
application for maximizing light penetration depth in tissue. Beyond this wavelength, water 
absorption in tissue leads to shallow penetration. Therefore, pushing LSPR wavelength of Au 
NP into the spectral range of 1300 nm is an important issue for biomedical application. For 
this purpose, Au nanoring (NR) is a good choice. The fabrication of Au NRs on a substrate has 
been reported [58–60]. The LSPR wavelength of such an Au NP in water can approach the 
spectral range of 1300 nm. However, the study of transferring Au NRs from substrate into 
water solution for biomedical application is still quite rare. 
Due to its interference (coherence) detection nature, optical coherence tomography (OCT) 
is  a  suitable  approach  for  monitoring  the  LSPR  of  Au  NPs  [61,62].  At  LSPR,  coherent 
scattering and absorption of metal NPs are enhanced. Hence, resonant Au NPs can be detected 
by  OCT  scanning  with  high  sensitivity.  Swept-source  OCT  systems  based  on  sweeping-
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diagnosis [63–65]. Besides Doppler OCT, speckle variance OCT represents a powerful tool 
for monitoring moving subjects in bio-tissue, particularly when the motions of the subjects do 
not follow a regular pattern like the case of blood flow in microvasculature [66,67]. In speckle 
variance OCT, by calculating the inter-frame intensity variation of structural images, in which 
the  contrast  is  based  on  different  time-varying  properties  of  moving  subjects  versus 
background tissue components, the general motion information of the moving subjects can be 
obtained. This approach is suitable for tracking the diffusion of resonant metal NPs in bio-
tissue. In this paper, characterizing the LSPR properties of Au NRs and tracking resonant Au 
NR transport in a bio-tissue with OCT scanning are reported. We first prepare Au NR water 
solution, in which the LSPR wavelength is longer than 1200 nm such that the LSPR of the 
delivered Au NRs in a mouse liver sample can enhance backscattering for effective OCT 
scanning by using an OCT system of 1310 nm in the central wavelength of its light source 
spectrum. With OCT scanning, the diffusion of Au NRs can be tracked by observing the 
variation of the average A-mode scan profile and by evaluating the center-of-mass depth of 
speckle variance distribution at different delay times after a droplet of Au NR solution is 
applied onto the sample surface. Speckle variance OCT is a useful technique for monitoring 
irregular object motion in a tissue sample. We use the speckle variance signal to trace the Au 
NR  diffusion  in  the  liver  sample  and  observe  systematical  diffusion  behaviors.  The 
understanding  of  such  behaviors  will  help  us  in  designing  schemes  for  various  Au  NP 
applications. 
2. Samples and methods 
For fabricating Au NRs on a substrate, we first use a colloidal lithography process through 
electrostatic adsorption of polystyrene colloidal particles (Duke Scientific Corporation) on a 
SiO2  layer  of  20  nm  in  thickness,  which  is  coated  on  a  sapphire  substrate  with  plasma-
enhanced chemical vapor deposition [68]. Two samples are prepared with colloidal particle 
diameters at 150 (sample A) and 100 (sample B) nm. Then, an Au thin film of ~30 nm in 
thickness is deposited on the top to serve as the source of secondary sputtering, which is 
implemented  with  a  reactive  ion  etching  (RIE)  process.  In  this  process,  CHF3  is  used  as 
etchant for forming Au ring structures around the colloidal particles through the mechanism of 
secondary sputtering. At the same time, the residual Au atoms are removed. Next, an O2 
plasma etching procedure is used to remove the colloidal particles, leaving Au NRs on SiO2-
coated sapphire substrate. Typical scanning electron microscopy (SEM) images of the Au NRs 
of samples A and B on the SiO2-coated sapphire substrate are shown in Fig. 1(a) and 1(b), 
respectively. Here, in samples A and B, the average outer diameters of those Au NRs are 
about 174 and 118 nm and the inner diameters are 150 and 100 nm, respectively. The average 
thickness of the NRs in sample A (B) is about 12 (9) nm. 
 
Fig. 1. SEM images of the Au NRs on substrate in samples A (a) and B (b). 
The Au NRs are then surface modified by APTS ((3-aminopropyl) trimethoxysilane, 97%, 
Alfa Aesar) to prevent them from aggregation in water. In this process, a mixture of 1:1 water-
ethanol solution (100 mL) is combined with 50 μL of APTS, and is maintained at pH 10 by 
adding NH3 solution. The substrate samples are immersed in this mixture for more than 24 
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substrate-attached Au NRs into water solution, the substrate samples are immersed in a KOH 
solution (85%, 13.6% w.t. in water) for 15 min to etch the SiO2 layer between Au NRs and 
sapphire substrate, followed by a step of gentle rinse with de-ionized water to remove residual 
KOH. Then, the substrate sample is placed in a glass bottle filled with a proper amount of de-
ionized water. After sonication, the Au NRs are transferred into water solution. To avoid the 
aggregation  of  Au  NRs  and  hence  increase  their  stability,  PEG-Thiol  (mPEG-Thiol-5000, 
Laysan Bio Inc., Arab, AL) is added to the NR solution to make a concentration at 2.5 × 10
5 
M. The mixture is then incubated at room temperature for 20 hours. It is noted that APTS is 
used to avoid aggregation when Au NRs are transferred into water solution. PEG-Thiol is used 
for maintaining long-term stability of Au NR solution. Figures 2(a) and 2(b) show the close-
up SEM images of two and one Au NRs of samples A and B, respectively, after they are lifted 
off and placed on Si substrates. The images demonstrate that the inner and outer diameters of 
the NRs change along their ring axes. It is estimated that in an Au NR, the variations of inner 
and  outer  diameters  can  be  as  large  40%  from  the  individual  maximum  values  in  either 
sample. 
 
Fig. 2. Close-up SEM images of the Au NRs after liftoff in samples A (a) and B (b). 
In  OCT  scanning  experiments,  a  swept-source  OCT  system  is  used.  In  this  system,  a 
sweeping-frequency laser source with the output spectral peak at 1310 nm (the spectrum is 
shown in Fig. 3) is used as the light source. The light source is connected to a Mach-Zehnder 
interferometer, which consists of two optical couplers and two circulators. The interference 
fringe signal is detected by a balanced photo-detector and sampled by a high-speed digitizer. 
The achieved system sensitivity and axial resolution in tissue are 103 dB and 6 μm (in tissues) 
at the depth of 1 mm, respectively. It takes about 0.1 s to complete a two-dimensional image 
of 1.3 mm in lateral dimension. The detailed descriptions about the OCT system and operation 
can be found in Refs. [63–65]. It is noted that for obtaining an OCT image in this paper, we 
first make 1950 A-mode scans in the lateral range of 1.3 mm with one scan every 0.67 μm. To 
reduce  the  background  noise,  we  take  the  average  of  three  adjacent  A-mode  scans  for 
composing an OCT image. Therefore, there are 650 A-mode scans with one scan every 2.01 
μm in one image. Since all the samples are scanned under the same OCT operation conditions, 
the variation of absolute OCT signal intensity from one image to another must be small. The 
pixel size in an OCT image is about 7 μm (depth) x 5 μm (width). 
For demonstrating the transport of delivered Au NRs in tissue, we choose mouse liver as 
sample because of its structure uniformity (suitable for the first-stage study), our capability of 
keeping  the  sample  fresh  for  making  the  condition  close  to  in  vivo  experiment,  and  the 
biomedical importance in understanding NP migration behavior in liver. A male C57/black 
mouse,  7–8  weeks  old,  fed  chow  and  water  ad  libitum  under  standard  light-dark  cycle 
conditions was subjected to simple laparotomy by midline incision after cervical translocation. 
The five liver lobes of the mouse were resected and rinsed briefly with Ringer’s solution, then 
all vasculature were sealed immediately using sterile hydroactive gel (Convatec, New Jersey). 
The liver lobes were kept under 100% humidified air at room temperature, and their visceral 
peritonea  were  torn  apart  from  falsiform  ligament  to  expose  the  hepatic  tissue  before 
application of Au NR solution. For OCT scanning, a solution droplet of Au NRs (about 3 μL) 
is  applied  to  the  surface  of  a  mouse  liver  sample.  An  OCT  image  of  1.3  mm  in  lateral 
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results after Au NR delivery. After the application of the solution droplet, an OCT image is 
obtained every 10 sec for 60 min at the same location. 
3. Localized surface plasmon properties of Au nanorings 
The estimation of Au NR concentration in water solution starts with the calculation of the total 
Au NR number on the substrate based on the SEM observation [68]. The NR concentrations in 
the  solutions  of  samples  A  and  B  are  estimated  to  be  1.09  x  10
9  and  2.01  x  10
9  cm
3, 
respectively, by assuming that 40% NRs are lost in the process of transferring NRs into water 
solution. The water solutions of the two samples are then condensed with centrifugation under 
the condition of 5000 rpm for 40 min by a factor of about 27 to give the final concentrations of 
2.94 x 10
10 and 5.43 x 10
10 cm
3 in samples A and B, respectively. These values are essentially 
consistent  with  the  concentration  estimates  from  the  measurement  of  inductively  coupled 
plasma mass spectrometry, which results in 2.40 x 10
10 and 8.03 x 10
10 cm
3 for samples A 
and  B,  respectively.  It  is  noted  that  with  the  aforementioned  concentrations,  the  average 
distances between two neighboring Au NRs are ~3 μm in sample A and ~2.5 μm in sample B. 
In such a solution, the LSPR coupling between neighboring Au NRs must be weak. Optical 
transmission of the water solutions of Au NRs are measured with a UV-vis spectrophotometer 
(Jasco V-570) to show the spectral variations of extinction cross sections of the two samples in 
Fig. 3 (the left ordinate). The extinction cross sections are obtained by dividing the measured 
extinction coefficients by the Au NR concentrations given above. Here, one can see the major 
peaks of extinction, corresponding to the LSP dipole resonances in water, at 1240 and 1030 
nm for samples A and B, respectively. In this figure, the spectrum of the sweeping-frequency 
laser source of the used OCT system is also shown for comparison (the right ordinate). The 
light source spectrum with its peak at 1310 nm and spectral full-width at half-maximum at 
~100 nm is covered by the long-wavelength side of the LSP dipole resonance range of sample 
A. However, the LSP dipole resonance range of sample B is quite far away from the OCT 
light source spectrum. The secondary peaks of the extinction spectra in Fig. 3 correspond to 
the mixture of the higher-order resonance across the ring and the resonance along the ring 
axis. It is expected that the LSP dipole resonance peak red shifts and overlaps better with the 
OCT light source spectrum when the Au NRs are delivered into tissue, which has a higher 
refractive index of ~1.4. From Fig. 3, one can see that the extinction cross sections of sample 
A (B) at the individual LSPR wavelength and 1310 nm are 5.56 x 10
10 and 5.22 x 10
10 cm
2 
(2.84 x 10
10 and 1.21 x 10
10 cm
2), respectively. Those numbers are also shown in Table 1 for 
comparing with the corresponding values from other methods later. 
To confirm the level of Au NR extinction cross section, we place a droplet of Au NR 
solution on a coverslip for OCT scanning. Figures 4(a) and 4(b) show the OCT scanning 
images of samples A and B, respectively. Because the lateral scanning is implemented by the 
swing of a galvanometer, the image surfaces show slightly concave geometries. The stronger 
and  weaker  OCT  signal  intensities  from  the  solution  droplets  in  Figs.  4(a)  and  4(b), 
respectively, indicate the different scattering cross sections at 1310 nm between samples A 
and B. By averaging all the A-mode scan profiles of the OCT images in Figs. 4(a) and 4(b) 
and then multiplying a fixed-focus effect function, f, of [69] 
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   (1) 
where z is the depth, zcf is the depth of the focal point, and zR is the Rayleigh length, which is 
equal to the field of view and is around 154 μm, we can plot the two curves in Fig. 5 for 
demonstrating the decay profiles of samples A and B. It is noted that in averaging the A-mode 
scan profiles, the sample surface points are aligned with each other. In Fig. 5, one can see that 
in samples A and B, when the depths are smaller than 125 and 150 μm, respectively, the 
curves in the semi-log scale show linear variations, from which extinction coefficients can be 
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coefficients are 14.30 and 5.83 cm
1 for samples A and B, respectively. The Au NR extinction 
cross  section  can  be  obtained  from  the  extinction  coefficient  divided  by  the  Au  NR 
concentration. By using the aforementioned estimated Au NR concentrations, we can obtain 
4.86 x  10
10 and 1.07  x 10
11 cm
2 for  the extinction cross sections of samples A  and B, 
respectively, at 1310 nm. These values are reasonably consistent with those calibrated from 
transmission measurement at the same wavelengths, which are 5.22 x 10
10 and 1.21 x 10
10 
cm
2 for samples A and B, respectively (see Table 1). The average OCT intensity profiles in 
the deeper portions shown in Fig. 5 are not consistent with the straight-slope trends of the 
shallower portions. The enhanced OCT intensities, with respect to the straight-slope trends, in 
the deeper portions can be attributed to the sedimentation of Au NRs in the solution droplets. 
However,  the  sedimentary  Au  NRs  do  not  directly  contact  the  coverslip.  They  are  still 
suspended in the deeper portions of the solution droplets. In this situation, the deeper portions 
have higher NR concentrations than those in the shallower portions. Hence, the extinction 
cross section evaluations based on the overall average NR concentrations of the droplets can 
be underestimated. 
 
Fig. 3. Spectral variations of extinction cross sections of the NRs in water in the two samples 
obtained from optical transmission measurement. 
Table 1. Extinction cross sections of samples A and B obtained from different methods, 
including transmission, OCT scanning, and simulation 
x10
10 cm
2  Sample A  Sample B 
Resonance wavelength 
(1240 nm) 
1310 nm  Resonance wavelength 
(1030 nm) 
1310 nm 
Transmission  5.56  5.22  2.84  1.21 
OCT scanning  —  4.86  —  1.07 
Simulation  31.1  23.9  16.9  1.3 
To  further  understand  the  resonance  behaviors  of  the  fabricated  Au  NRs,  numerical 
simulations  based  on  the  finite-element  method  are  performed.  In  our  simulation,  the 
resonance behaviors of the Au NRs are obtained with the excitation light incident along the 
ring axis. In Fig. 6, the extinction, scattering, and absorption cross sections as functions of 
wavelength of the two samples with ambient refractive index at 1.33 corresponding to the 
situation of an NR in water are shown. The used NR parameters include the outer diameter at 
179 (120) nm, inner diameter at 149 (97) nm, and height at 95 (60) nm for sample A (B). For 
simulations, the dispersive dielectric constant of Au follows the experimental data in Ref. 
[70]. In Fig. 6, one can see that scattering is stronger than absorption around the resonance 
wavelength in either sample A or B. In OCT scanning, the enhanced backscattering can be due 
to either the LSPR-enhanced scattering or absorption of Au NRs. With enhanced absorption of 
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that local backscattering is enhanced. 
 
Fig. 4. OCT images of Au NR solution droplets on coverslip in samples A (a) and B (b). 
 
Fig. 5. Average A-mode scan profiles multiplied by a fixed-focus effect function of the two 
samples. 
The extinction cross sections of samples A and B at their individual LSPR wavelengths 
and at 1310 nm are shown in the row of simulation in Table 1. In this table, we compare the 
results of  the extinction  cross  sections of  the  two  samples  from  three methods,  including 
optical transmission measurement, OCT scanning, and simulation. Here, one can see that the 
extinction  cross  sections  at  1310  nm  obtained  from  OCT  scanning  and  transmission 
measurement  are  quite  consistent.  The  slightly  lower  values  from  OCT  scanning  can  be 
attributed to the overestimated NR concentrations in the shallower portions of Fig. 5, in which 
the OCT signals are used for calibrating the extinction cross sections. Except that of sample B 
at  1310  nm,  the  simulation  results  are  significantly  larger  than  those  from  transmission 
measurement.  At  individual resonance  wavelengths,  the simulation  results  are  5.6-6  times 
those from transmission measurement for both samples. It is noted that the simulation results 
are obtained under the assumption of optimized excitation of LSPR in a single NR and hence 
represent the case of perfectly aligned Au NR distribution of negligible mutual coupling. The 
significantly  smaller  extinction  cross  sections  from  experiments  can  be  attributed  to  the 
following four factors. First, due to the random orientation distribution of Au NRs in water, 
the average extinction cross section drops by a certain percentage. Second, because of the non-
uniform distribution of Au NR geometry, the LSPR spectrum is broadened. In this situation, 
the peak level at the LSPR wavelength is reduced and the spectral wing levels, particularly the 
tails, are enhanced. Therefore, as shown in Table 1, at 1310 nm, the simulation results are 
larger than those from transmission measurement by only 4.6 and 1.07 times in samples A and 
B, respectively. The third factor is related to the changing ring diameter along its axis in a 
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concentrations can be overestimated such that the experimentally calibrated extinction cross 
sections are underestimated. 
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Fig. 6. Simulation results of the extinction (Ext), scattering (Sca), and absorption (Abs) cross 
sections as functions of wavelength of a single Au NR of samples A and B. The LSPR is 
excited with a plane wave incident along the ring axis. 
4. OCT scanning results of mouse liver samples with delivered Au nanorings 
Figures 7(a)–7(d) show the OCT images of a mouse liver sample before, 0, 30, and 60 min 
after the application of an Au NR solution droplet of sample A. In Fig. 7(b), one can see the 
image  of  the solution droplet  with strong  backscattering  of  resonant Au  NRs.  Within  the 
mouse liver sample, a brighter stripe at the depth between 400 and 600 μm can be seen in each 
figure that is irrelevant to Au NR delivery. The depth of the brighter stripe corresponds to the 
location of the focal point of the used objectives for focusing light into the sample in OCT 
scanning. The sample depth of the focal point may vary from sample to sample because of 
their different sizes. To observe the transport of Au NRs in the liver sample, we evaluate the 
variance of OCT signal intensity at each image pixel based on four successive OCT images 
(10 sec separation between two successive images) to form the speckle variance images in  
Fig. 8 [66,67]. Figures 8(a)–8(e) show the speckle variance images in the liver sample at 15, 
22.5, 30, 45, and 60 min after the application of the Au NR solution droplet (sample A). For 
clearly  demonstrating  the  speckle  variance  distributions  in  Figs.  8(d)  and  8(e),  the  signal 
intensities in these two figures have been numerically enhanced by 50 times. The intensity 
distributions in Figs. 8(a)–8(e) are related to the motion speed of Au NR diffusion. We can 
only show such images taken after the solution droplet is completely diffused into the liver 
sample (~15 min later) because the solution droplet on the sample surface distorts the images 
and leads to artifacts in evaluating the speckle variance. From Figs. 8(a)–8(e), one can see that 
the distribution of high speckle variance moves to deeper sample layers with time. Although 
the stronger OCT signal intensity near the focal point may result in a higher variance level, the 
observation of the speckle variance variation is not affected by the focal point issue, as to be 
demonstrated later. To provide a more complete picture of resonant Au NR diffusion in the 
mouse liver sample, Media 1 shows the motion pictures of OCT scanning for 60 min starting 
at  the  application  of  the  solution  droplet.  Media  2  shows  the  motion  pictures  of  speckle 
variance mapping for 45 min starting at the time of complete diffusion of the solution droplet 
into the liver sample. 
On the other hand, when a solution droplet of sample B is applied to a liver sample, the 
weak LSPR leads to quite different results, as demonstrated in Fig. 9. In this case, although the 
Au NRs in the solution droplet can also produce observable backscattering in OCT scanning, 
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bright spot in Fig. 9(b) is an artifact caused by the surface reflection of the solution droplet. 
With sample B, Au NRs are expected to also diffuse into the mouse liver sample. However, 
due to the weak LSPR of this sample at 1310 nm, we can hardly observe any change in OCT 
scanning  images  after  the  Au  NRs  are  delivered  into  the  liver  sample,  as  shown  in  
Figs. 9(a)–9(d), which show the images taken before, 0, 30, and 60 min after the application of 
the  solution  droplet,  respectively.  Meanwhile,  little  information  can  be  obtained  from  the 
speckle variance analysis of the OCT scanning images, as demonstrated in Figs. 10(a)–10(c), 
in which the speckle variance images in the liver sample at 15, 22.5, and 30 min, respectively, 
after the application of the Au NR solution droplet are shown. It is noted  that to clearly 
demonstrate the images in Figs. 10(a)–10(c), the speckle variance signal strengths in these 
images are numerically enhanced by four times. In our experiment, because sample B has a 
higher Au NR concentration than that of sample A, the overall weaker LSPR behavior in 
sample B must be due to its weaker LSPR of an individual Au NR. We also repeated the OCT 
scanning on a mouse liver sample by applying a droplet of pure water. In this situation, the 
scanning results are similar to those in the case of non-resonant Au NR delivery. 
 
Fig. 7. (Media 1) OCT images of a mouse liver sample taken before (a), 0 (b), 30 (c), and 60 
min (d) after the application of an Au NR solution droplet of sample A onto the sample surface. 
 
Fig. 8. (Media 2) Speckle variance images of the mouse liver sample including Au NRs of 
sample A, evaluated based on the OCT images, at 15 (a), 22.5 (b), 30 (c), 45 (d), and 60 (e) min 
after the application of an Au NR solution droplet. To clearly demonstrate the images in parts 
(d) and (e), the speckle variance signal strengths in these two images are numerically enhanced 
by 50 times. 
From Figs. 7–10 and Media 1 and Media 2, one can see that the sample surface level drops 
with delay time after the solution droplet is completely diffused into a sample. This behavior 
is particularly clear in the early stage of OCT scanning. It is due to sample shrinkage during 
OCT scanning, particularly in the upper portion of the sample, caused by sample dry up and 
water  diffusion  into  deeper  layers.  The  shrinkage  range  can  be  estimated  by  tracking  the 
distance  between  the  image  top  end  and  the  sample  surface  at  the  center  in  the  lateral 
dimension of an image as a function of delay time. This distance as a function of delay time in 
the experiment with sample A is shown in the red curve (with the left ordinate) and the fitting 
curve  with  a  fifth-order  polynomial  (the  black  dashed  curve)  in  Fig.  11.  By  taking  the 
derivative of the fitting curve, we can obtain the sample shrinkage speed, as shown in the blue 
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min, the sample shrinkage speed becomes lower than 7.5 μm/min. In this situation, within 40 
sec, over which a data point of speckle variance is evaluated, the sample shrinkage range is 
smaller than 5 μm. This range is smaller than the depth pixel size of 7 μm. In other words, 
between 15 and 25 min in delay time, the observed speckle variance signals can be mainly 
caused by sample shrinkage. However, beyond 25 min in delay time, the observed speckle 
variance signals are essentially due to Au NR diffusion. 
 
Fig. 9. OCT images of a mouse liver sample taken before (a), 0 (b), 30 (c), and 60 min (d) after 
the application of an Au NR solution droplet of sample B onto the sample surface. 
 
Fig. 10. Speckle variance images of the mouse liver sample including Au NRs of sample B, 
evaluated based on the images in Fig. 9, at 15 (a), 22.5 (b), and 30 (c) min after the application 
of an Au NR solution droplet. To clearly demonstrate the images, the speckle variance signal 
strengths in these images are numerically enhanced by four times. 
To further understand the Au NR diffusion behavior in the mouse liver sample, we take the 
average of all the A-mode scan profiles in the OCT image taken at a particular time and plot 
the result in Fig. 12. Before the average, the sample surface points of all the A-mode scan 
profiles are aligned with each other. In Fig. 12, we show the average A-mode scan profiles 
(thick curves) before, 20, 30, and 60 min after the application of the solution droplet of sample 
A for comparison. Here, for reasonable comparison, the surface points of the average A-mode 
profiles at different delay times are also aligned with each other. In Fig. 12, the peaks between 
100 and 150 μm in depth are caused by sample surface scattering. Here, one can see that 
surface  scattering  strength  increases  with  delay  time.  This  phenomenon  is  caused  by  the 
accumulation of Au NRs (with water) on the sample surface. Through continuous OCT light 
illumination, the surface Au NR solution is gradually dried up and condensed such that the 
surface scattering becomes stronger and stronger with delay time. This phenomenon can also 
be clearly seen in Figs. 7(c) and 7(d). The surface speckle variance signals shown in Figs. 8(b) 
and  8(c)  are  caused  by  the  sample  shrinkage  process  during  OCT  scanning.  Surface 
accumulation of Au NRs should also occur in the case of sample B. However, because the 
non-resonant Au NRs cannot be clearly seen with OCT scanning, we cannot observe enhanced 
surface scattering effect in Fig. 9(c), 9(d), 10(b), or 10(c). By comparing the average profiles 
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the profile peak generally shifts to larger depths with increasing delay time. To more clearly 
compare the variation trend of the average A-mode profile beyond 150 μm in depth, they are 
fitted with second-order polynomials, which are plotted as the smooth thin curves in Fig. 12. 
Based on the fittings, one can see that at 20, 30, and 60 min in delay time, the profile peaks are 
located at 314, 414, and 472 μm in depth (with respect to the individual sample surfaces), 
respectively.  Such  a  trend  cannot  be  caused  by  sample  shrinkage,  which  should  lead  to 
reduced profile peak depth if the peak is produced by certain feature other than diffused Au 
NRs, such as the focal point or a tissue structure of strong backscattering,. This trend clearly 
demonstrates the diffusion of Au NRs into the liver sample to reach a deeper layer after a 
longer transport time. It is noted that beyond 150 μm in depth, the dot-dashed curve, which 
describes the condition before droplet application, has a maximum around 450 μm in depth. 
This depth roughly corresponds to the focal point of OCT light illumination. The depth of 
focal  point  around  450  μm  may  affect  the  determination  of  the  Au  NR  diffusion  range, 
particularly in the case of 60 min in delay time. With the LSPR of the delivered Au NRs, the 
OCT signal intensity is expected to become stronger. However, in Fig. 12, the profile level of 
the  curve  representing  the  condition  before  the  droplet  application  (the  dot-dashed  curve) 
beyond 150 μm in depth is comparable to those after the droplet application. This result is 
attributed  to  the  significantly  weaker  surface  backscattering  in  the  case  before  droplet 
application. If the surface scattering strengths of all those cases in Fig. 12 were the same, the 
OCT signal intensity level beyond 150 μm in the case before droplet application would be 
lower than those of droplet application. 
 
Fig. 11. Distance between the image top end and the sample surface at the center in the lateral 
dimension of an image as a function of delay time in the experiment with sample A (the red 
curve) and the fitting with a fifth-order polynomial (the black dashed curve) in the left ordinate. 
Sample shrinkage speed is also shown in the blue curve (in the right ordinate). 
As mentioned earlier, the distribution of high speckle variance level shifts to a deeper layer 
with delay time. For demonstrating this trend more clearly, we evaluate the center-of-mass 
depth of the speckle variance distribution as a function of delay time (starting at 25 min in 
delay time) to plot the curves in Fig. 13 for the cases of samples A and B. For comparison, the 
result in the case of applying a pure water droplet onto a liver sample is also shown. It is noted 
that the zero level of the center-of-mass depth is set at the individual sample surface at each 
delay time such that the sample shrinkage factor can be essentially removed. The thin lines in 
Fig. 13 represent the least-square fitting slopes of the data of center-of-mass depth. Because in 
the cases of water and sample B, the delivered substances do not significantly change the OCT 
scanning images, we cannot observe any major feature except a slightly increasing trend in the 
curves of center-of-mass depth. With resonant Au NRs, the curve of sample A in Fig. 13 
clearly  shows  an  increasing  slope  of  6.40  μm/min.  Because  the  center-of-mass  depth  of 
speckle variance represents the location of major NR transport, the slope of 6.40 μm/min can 
be regarded as the migration speed of Au NRs in mouse liver in the diffusion process (starting 
at 25 min after the NR solution application). From the speckle variance images, one can also 
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increases. Figure 14 shows the depth standard deviations of speckle variance in the three cases 
of Fig. 13. Again, the thin straight lines here represent the least-square fitting results. In the 
cases of sample B and water, only slightly decreasing trends are seen. The clear increasing 
trend with a slope of 7.55 μm/min in the case of sample A indicates the broadening process of 
moving NR distribution with delay time in the mouse liver sample. 
 
Fig. 12. Average A-mode scan profiles (thick curves) of the OCT images taken before, 20, 30, 
and 60 min after the application of an Au NR solution droplet of sample A. The second-order 
polynomial thin curves are used to fit the average A-mode scan profiles for finding the depths 
of maximum intensities for the cases of 20, 30, and 60 min in delay time. 
 
Fig. 13. Center-of-mass depths of speckle variance distributions in the cases of samples A and 
B, and water delivery as functions of delay time. 
It is noted that besides Au NR diffusion, the evaluations of the center-of-mass depths and 
depth standard deviations of speckle variance distributions can be affected by other factors, 
such as the focusing of the illumination light beam. However, because the samples in the three 
cases of resonant Au NR, non-resonant Au NR, and water applications are scanned under the 
same OCT operation conditions, the effects of other factors should be common among the 
three cases. The observed different results between the three cases must be caused by the 
different LSPR behaviors of diffused Au NRs. Because OCT scanning monitors the refractive 
index variation in the sample, the recorded OCT signals can be due to the LSPR-enhanced 
scattering of Au NRs. They can also be due to the refractive index change resulting from local 
heating, which is caused by LSPR-enhanced absorption of Au NRs. However, it is difficult to 
determine the dominating factor. 
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Fig. 14. Depth standard deviation of speckle variance distributions in the cases of samples A 
and B, and water delivery as functions of delay time. 
5. Conclusions 
In  summary,  we  have  demonstrated  the  preparation  of  water  solutions  of  Au  NRs  with 
different LSPR wavelengths. The LSPR-induced extinction cross sections at 1310 nm were 
estimated with OCT scanning of solution droplets on coverslip. The results were reasonably 
consistent  with  the  data  at  individual  LSPR  wavelengths  and  at  1310  nm  obtained  from 
transmission measurements and numerical simulations.  The  resonant and non-resonant Au 
NRs  were  then  delivered  into  mouse  liver  samples  for  tracking  Au  NR  diffusion  in  the 
samples through continuous OCT scanning. With resonant Au NRs, the average A-mode scan 
profiles  of  OCT  scanning at  different  delay  times  clearly  showed  the  extension of  strong 
backscattering depth. The calculation of speckle variance among successive OCT scanning 
images, which could be used to represent the local transport speed of Au NRs, led to the 
demonstrations of downward propagation and spreading of major Au NR motion spot with 
time. In one of the future efforts, Au NR of a smaller diameter with its LSPR wavelength in 
tissue being maintained close to 1300 nm will be designed and fabricated. Such a structure can 
be implemented by decreasing the ring thickness when the ring diameter is reduced. 
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